Skip to content

Prospective, Randomized Study of the Impact of a Education Program for Patients Suffering From Low Back Pain

Prospective, Randomized Study of the Impact of a Education Program for Patients Suffering From Low Back Pain

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT02564185
Acronym
TENS
Enrollment
98
Registered
2015-09-30
Start date
2010-09-30
Completion date
2015-10-31
Last updated
2017-02-01

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Low Back Pain

Brief summary

According to the WHO, therapeutic education is intended to help patients acquire or maintain the skills they need to optimally manage living with a chronic disease. Low back pain is frequent and therapeutic education could be a promising option. The purpose of the study is to evaluate the impact of a therapeutic education program for patients suffering from low back pain.

Interventions

OTHERUsual practice
OTHEREducation program

Sponsors

Hopital Foch
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to 75 Years
Healthy volunteers
No

Inclusion criteria

* Low back pain * Treatment with transcutaneous electrical nerve stimulation (TENS)

Exclusion criteria

* Contra-indication of TENS * Patients with mental disorders * Lack of autonomy or patients living alone at home without help * Concomitant inclusion in another research on the treatment of pain

Design outcomes

Primary

MeasureTime frameDescription
Quality of life6 monthsEIFEL functional disability scale (Gagnon et al, Annals Phys Med Rehab, 2009, 1, 3-16).

Secondary

MeasureTime frameDescription
Pain6 monthsNumerical scale
Neuropathic pain6 monthsDN4 questionnaire
Social impact6 monthsChanges in the employment status
Evaluation of the program6 monthsSelf-administered questionnaire

Countries

France

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026